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Summary
Immature CD4+CD8+ thymocytes, which are generated
in the thymic cortex, are induced upon positive selec-
tion to differentiate into mature T lymphocytes and re-
locate to the thymic medulla. It was recently shown
that a chemokine signal via CCR7 is essential for the
cortex-to-medulla migration of positively selected thy-
mocytes in the thymus. However, the role of the cor-
tex-to-medulla migration in T cell development and
selection has remained unclear. The present study
shows that the developmental kinetics and the thymic
export of mature thymocytes were undisturbed in
adult mice lackingCCR7 or its ligands (CCR7L). The in-
hibition of sphingosine-1-phosphate-mediated lym-
phocyte egress from the thymus led to the accumula-
tion of mature thymocytes in the cortex of CCR7- or
CCR7L-deficient mice, unlike the accumulation in the
medulla of normal mice, thereby suggesting that ma-
ture thymocytesmay be exported directly from the cor-
tex in the absence of CCR7 signals. However, the
thymocytes that were generated in the absence of
CCR7 or CCR7L were potent in causing autoimmune
dacryoadenitis and sialadenitis in mice and were thus
incapable of establishing central tolerance to organ-
specific antigens. These results indicate that CCR7-
mediated cortex-to-medullamigration of thymocytes is
essential for establishing central tolerance rather than
for supporting thematuration or export of thymocytes.
*Correspondence: takahama@genome.tokushima-u.ac.jpIntroduction
The thymus is an organ that supports the differentiation
and selection of T lymphocytes (Miller, 1961; Ritter and
Boyd, 1993; Anderson and Jenkinson, 2001). Lymphoid
progenitor cells enter the thymus via the surrounding
mesenchymal layer before vascularization during fetal
development (Bleul and Boehm, 2000) and via blood
vessels that are enriched at the cortico-medulla junction
in adulthood (Lind et al., 2001). Several chemokines
have been suggested to play a crucial role in the posi-
tioning of T precursor cells to the subcapsular zone of
the outer cortex of the thymus (Plotkin et al., 2003; Mis-
slitz et al., 2004; Benz et al., 2004; Gray et al., 2005; Liu
et al., 2005), where immature CD4+CD8+ double-positive
(DP) thymocytes are newly generated (Ritter and Boyd,
1993; Takahama et al., 1994). The DP thymocytes crawl
through the cortical environment, seeking to encounter
the self-MHC-peptide complex expressed by various
stromal cells in the cortex, including the cortical thymic
epithelial cells (cTEC) (Bousso et al., 2002). Upon TCR
engagement by the MHC-peptide ligands, the DP thy-
mocytes stop crawling and initiate the signaling pro-
cesses for positive and negative selection, which result
in further differentiation into CD4+CD82/CD42CD8+
single-positive (SP) thymocytes and apoptotic deletion,
respectively (Bousso et al., 2002; Palmer, 2003). Concur-
rently to the differentiation into SP thymocytes, posi-
tively selected thymocytes are relocated to the medulla
(Ritter and Boyd, 1993; van Ewijk et al., 1994; Witt et al.,
2005). The newly generated SP thymocytes are semima-
ture, being functionally incompetent and susceptible
to various apoptotic signals including dexamethasone,
and undergo further maturation to become mature
SP thymocytes that are functional, dexamethasone-
resistant, and CD62LhighCD69low (Reichert et al., 1986a;
Ramsdell et al., 1991; Kishimoto and Sprent, 1997; Gabor
et al., 1997; Sheard et al., 2004). The mature SP thymo-
cytes are exported from the thymus via chemotaxis
toward sphingosine-1-phosphate (S1P) in the circulation
and are systemically distributed as functional yet naive
T lymphocytes (Matloubian et al., 2004; Allende et al.,
2004). The maturation of SP thymocytes is thought to
occur within the medulla (Egerton et al., 1990; Scollay
and Godfrey, 1995), and the export to the circulation is
thought to occur through the perivascular space in the
medulla (Ushiki, 1986; Kato, 1997).
In the thymic medulla, medullary thymic epithelial
cells (mTEC) specifically express the nuclear protein
AIRE, which is essential for the promiscuous expression
of organ-specific self-antigens by mTEC (Zuklys et al.,
2000; Gotter and Kyewski, 2004). AIRE deficiency results
in autoimmune-polyendocrinopathy-candidiasis ecto-
dermal dystrophy (APECED) in human (Nagamine et al.,
1997; Aaltonen et al., 1997) and mouse (Anderson et al.,
2002; Liston et al., 2003; Kuroda et al., 2005). Thus,
AIRE expressed by mTEC is essential for establishing
the central tolerance of T lymphocytes to organ-specific
antigens. The molecular mechanisms involved in the dif-
ferentiation of thymic epithelial progenitor cells into
Immunity
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burn et al., 2002; Farr et al., 2002), although recent anal-
yses have shown that similar to the organogenesis of
lymph nodes and Peyer’s patches, the NFkB-mediated
signals via LTbR, TRAF6, NIK, and relB are critical for
the development of the thymic medulla that regulates
central tolerance (Burkly et al., 1995; Boehm et al.,
2003; Kajiura et al., 2004; Akiyama et al., 2005). It has
also been suggested that the thymic medulla contributes
to central tolerance by dendritic cells (DCs), which are of
hematopoietic origin and are predominantly localized
within the thymic medulla (Flotte et al., 1983; Fairchild
and Austyn, 1990). The average lifespan of the newly
generated SP thymocytes in the thymus is 12 days (Eger-
ton et al., 1990; Scollay and Godfrey, 1995). During this
period, the thymic medulla is thought to provide an envi-
ronment in which the SP thymocytes are induced to ma-
ture and are tuned to acquire central tolerance. However,
whether the medulla migration of positively selected thy-
mocytes is essential for the maturation of SP thymo-
cytes, for the acquisition of central tolerance, or for the
export from the thymus is unclear.
Previous studies with the chemotaxis assay and
mRNA measurement showed that CCR7 expression by
developing thymocytes is associated with the pheno-
typic stage of cortex-to-medulla migration, during the
development of immature DP thymocytes to mature
SP thymocytes (Kim et al., 1998; Campbell et al.,
1999). We have recently shown that CCR7 ligands
(CCR7L species CCL19 and CCL21) in the thymus are
predominantly produced by mTEC and are localized in
the medulla, whereas TCR engagement of immature
cortical DP thymocytes elevates the cell surface expres-
sion of CCR7 (Ueno et al., 2002, 2004). In mice deficient
in CCR7 or CCR7L, the mature SP thymocytes are
arrested in the cortex and do not accumulate in the
medulla (Ueno et al., 2004). These results indicate that
the CCR7 signals are essential for the migration of pos-
itively selected thymocytes from the cortex to the me-
dulla. By using mice that are deficient in CCR7 or
CCR7L, the present study addresses whether T cells
may be exported from the thymic cortex without accu-
mulation in the medulla and whether central tolerance
to organ-specific self-antigens may be affected by the
absence of medulla migration. We show that the phar-
macological inhibition of S1P-mediated thymocyte
egress in CCR7- or CCR7L-deficient mice results in the
accumulation of mature thymocytes in the cortex, sug-
gesting that mature thymocytes may be exported via
the S1P-dependent mechanism from the cortex in the
absence of CCR7 signals. We also show that in the
absence of CCR7-dependent medulla migration, mature
thymocytes are incapable of acquiring tolerance to
lacrimal and salivary glands and are potent in induc-
ing autoimmune exocrinopathy similar to Sjo¨gren’s
syndrome.
Results
S1P Blockade Induces Accumulation of Mature
Thymocytes in the Thymic Cortex of CCR7- or
CCR7L-Deficient Mice
We have previously shown that mice deficient in CCR7
or CCR7L were defective in the cortex-to-medulla mi-gration of thymocytes and that SP thymocytes gener-
ated in CCR7L-deficient (plt/plt, P/P) or CCR7-deficient
(7/7) mice were barely accumulated in the thymic me-
dulla (Ueno et al., 2004). SP thymocytes in these mutant
mice appeared normal in terms of frequency and un-
derwent maturation, including TCR responsiveness
and formation of surface phenotypes such as CD62L
and CD69 (Ueno et al., 2004). In vivo 5-bromo-2-deox-
yuridine (BrdU) labeling showed that SP thymocytes
and DP thymocytes in these mutant mice were nor-
mally generated according to the developmental kinet-
ics (Figure 1A). In addition, intrathymic FITC adminis-
tration showed that SP thymocytes in CCR7L- or
CCR7-deficient mice were normally exported from the
adult thymus to the circulation (Ueno et al., 2004).
These results indicate that in CCR7L- or CCR7-defi-
cient adult mice, SP thymocytes show normal matura-
tion without medulla accumulation and normal export
from the thymus.
The above results suggested the possibility that the
mature SP thymocytes generated in CCR7- or CCR7L-
deficient mice might be exported from the cortex with-
out migrating into the medulla. In order to examine this
possibility, the mice were administered FTY720, an im-
munosuppressive compound that is phosphorylated
in vivo by sphingosine kinases and acts as an S1P mi-
metic to sequester T lymphocytes in the thymus and
lymph nodes (Chiba et al., 1998; Brinkmann et al.,
2002). It was previously shown that S1P1, one of the S1P
receptors, is expressed by mature SP thymocytes and
that S1P1 is required for the egress of T lymphocytes
from the thymus and lymph nodes (Matloubian et al.,
2004; Allende et al., 2004). Among the thymocyte sub-
populations, S1P1 mRNA was highly expressed in SP
thymocytes rather than DP or double-negative (DN) thy-
mocytes (Matloubian et al., 2004; Allende et al., 2004;
also shown in Figure 1B). Within the SP thymocytes,
the S1P1 expression was predominantly detected in
the CD62LhighCD69low mature subpopulation rather
than the CD62LlowCD69high semimature subpopulation
(Matloubian et al., 2004; also shown in Figure 1B). Simi-
lar to S1P1 expression, CCR7 expression was much
higher in SP thymocytes than in DP or DN thymocytes
(Kwan and Killeen, 2004; Misslitz et al., 2004; also shown
in Figure 1B). Unlike S1P1 expression, however, CCR7
expression was detected in CD62LlowCD69high semi-
mature thymocytes as well as in CD62LhighCD69low
mature thymocytes (Figure 1B). The CCR7 mRNA ex-
pression levels measured by quantitative RT-PCR anal-
ysis agreed with the CCR7 surface expression levels
measured by flow cytometry analysis with CCL19-Ig
fusion protein (Figures 1C and 1D). CCR7highTCRbhigh
thymocytes contained both the CD62LlowCD69high semi-
mature compartment and the CD62LhighCD69low mature
compartment, whereas CCR7negative/lowTCRbhigh thymo-
cytes predominantly contained the CD62LlowCD69high
semimature compartment (Figure 1C). CCR7 expres-
sion was higher in CD62LhighCD69low mature thymo-
cytes than in CD62LlowCD69high semimature thymo-
cytes (Figure 1D). These results indicate that CCR7
expression is detected in both CD62LlowCD69high
semimature and CD62LhighCD69low mature thymo-
cytes, whereas S1P1 expression is detected predomi-
nantly in the CD62LhighCD69low mature subpopulation,
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167Figure 1. Expression and Function of CCR7 in Thymocyte Subpop-
ulations
(A) Kinetics of mature thymocytes in mice deficient in CCR7L (plt/plt,
P/P) and their heterozygous control mice (+/P). Thymocytes from
BrdU-treated adult mice were stained for CD4, CD8, and BrdU. Plots
show means and standard deviations (symbols and bars, respec-
tively; the number of mice used for individual plots ranged from
five to seven) of the frequency of BrdU-positive cells within the indi-
cated CD4/CD8 populations of thymocytes on the indicated day of
analysis. All the data sets between +/P and P/P groups were not sig-
nificantly different at all the indicated days of analysis in all of the in-
dicated thymocyte subpopulations (including the data on DN thymo-
cytes) by the Student’s t test.
(B) Adult thymocytes from B6 mice were two-color stained for CD4
and CD8 and sorted for DN, DP, CD4SP, and CD8SP populations.
Adult B6 thymocytes were also three-color stained for TCRb,
CD62L, and CD69 and were sorted for TCRbhighCD62LlowCD69high
semimature and TCRbhighCD62LhighCD69low mature subpopula-
tions. Purity was >97% for CD4/CD8 two-color-sorted fractions
and >87% for TCRb/CD62L/CD69 three-color-sorted fractions. Rel-
ative mRNA levels (means and standard errors; n = 3) obtained by
quantitative RT-PCR for S1P1 and CCR7, which were normalized
to GAPDH mRNA levels, are shown. Asterisk indicates p < 0.05 by
the Student’s t test. N.S., not significant.
(C and D) Adult B6 thymocytes were examined for CCR7 surface ex-
pression by using CCL19-Ig, which specifically detects CCR7 on the
cell surface. Cells were also stained with PE-labeled anti-TCRb anti-
body, FITC-labeled anti-CD62L antibody, and PE-Cy5-labeled anti-
CD69 antibody. Where indicated, data were gated for
TCRbhighCCR7high and TCRbhighCCR7negative/low cells (C) and
TCRbhighCD62LlowCD69high and TCRbhighCD62LhighCD69low cells
(D). Numbers indicate frequencies of cells within the indicated
boxes. Dotted lines indicate control staining profiles without
CCL19-Ig. Shown are representative results of four independent
measurements.suggesting that the CCR7-mediated medulla migration
and the S1P1-mediated thymocyte egress are differ-
ently and sequentially regulated during SP thymocyte
maturation.
Importantly, FTY720 treatment induced the accumu-
lation of SP thymocytes in CCR7- or CCR7L-deficient
mice as well as in normal mice (Figures 2A and 2B).
Among the SP thymocytes, the accumulation was spe-
cifically induced in the CD62LhighCD69low mature popu-
lation, in either the CD4SP or the CD8SP compartment
(Figures 2A and 2C). Thus, the FTY720-mediated S1P
blockade of thymocyte egress to the circulation results
in the accumulation of CD62Lhigh mature SP thymocytes
even in CCR7- or CCR7L-deficient mice, in which most
SP thymocytes are arrested in the cortex and are defec-
tive in migrating into the medulla.
It was therefore interesting to identify the location in
the thymus where mature thymocytes were accumulat-
ing upon FTY720 treatment in CCR7- or CCR7L-defi-
cient mice, as the location for this accumulation would
correspond to the microenvironment where S1P would
otherwise act to attract mature thymocytes into the cir-
culation. To this end, thymus sections from FTY720-
treated mice were stained with mature-thymocyte-
specific anti-CD62L antibody and either mTEC-specific
ER-TR5 or cTEC-specific ER-TR4 monoclonal anti-
bodies (Figure 3). In agreement with the increase in the
CD62Lhigh SP thymocyte population as determined by
flow cytometry analysis (Figure 2C), the FTY720 treat-
ment markedly increased the CD62Lhigh thymocyte
population in normal mice as well as in CCR7- or
CCR7L-deficient mice (Figure 3A). In a parallel analysis
of the sections, the increased CD62Lhigh cells were in-
deed shown to belong to CD4 or CD8 single-positive
thymocytes in normal and mutant mice (data not
shown), indicating that the CD62Lhigh thymocytes
increased in Figure 3A represented mature SP thymo-
cytes. Most remarkably, the FTY720-mediated accu-
mulation of CD62Lhigh mature thymocytes was pre-
dominantly detected in the cortex and not the medulla
of CCR7- or CCR7L-deficient mice, whereas the
CD62Lhigh mature thymocytes were accumulated pre-
dominantly in the medulla of control mice (Figure 3A).
In the cortex of FTY720-mediated CCR7- or CCR7L-
deficient mice and in the medulla of FTY720-mediated
control mice, the analysis at higher magnification de-
tected areas where CD62Lhigh thymocytes accumulated
around CD31+ endothelial vessels (Figure 3B). In some
of those areas, CD62Lhigh thymocytes were found
even within the perivascular space surrounded by
CD31+ endothelial and ER-TR7+ mesenchymal cells
(Figure 3C). In contrast, no or very few CD62Lhigh thymo-
cytes were found in the medulla of FTY720-treated
CCR7- or CCR7L-deficient mice and in the cortex of
FTY720-treated control mice (Figures 3A, 3B, and 3C).
These results indicate that upon FTY720 treatment,
the mature SP thymocytes in CCR7- or CCR7L-deficient
mice are accumulated in the cortex rather than the me-
dulla of the thymus and are found even in the cortical
perivascular space, suggesting the possibility that
mature thymocytes generated in CCR7- or CCR7L-
deficient mice may be exported from the cortex through
the cortical perivascular space in a S1P-dependent
manner.
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cytes by FTY720-Mediated S1P Blockade
Flow cytometry analysis of thymocytes from
CCR7L-deficient mice (plt/plt, P/P), CCR7-
deficient mice (7/7), and their heterozygous
control mice (+/P and +/7), which were
treated with either saline (S) or FTY720 (F).
The profiles of CD62L and CD69 in (A) were
gated for TCRbhigh cells. Numbers in (A) indi-
cate frequencies of cells within the quad-
rants.
(B and C) Means and standard errors (the
numbers of mice analyzed ranged from four
to 11 in [B] and three to six in [C]) of the abso-
lute numbers of indicated thymocyte sub-
populations are shown. Asterisk indicates
p < 0.05 and double asterisk indicates p <
0.005 by the Student’s t test.Intrathymic Localization of AIRE+ Epithelial Cells and
Dendritic Cells in CCR7- or CCR7L-Deficient Mice
We then addressed whether thymic function in inducing
central tolerance is affected in CCR7- or CCR7L-defi-
cient mice. It was previously reported that the thymic
medulla contributes to establishing central tolerance
by AIRE-expressing mTEC (Zuklys et al., 2000; Ander-
son et al., 2002; Liston et al., 2003; Kuroda et al., 2005)
and medulla-localized DCs (Fairchild and Austyn,
1990; Moore et al., 1994). We thus examined whether
AIRE+ mTEC and CD11c+ DCs were indeed localized
within the medulla in CCR7- or CCR7L-deficient mice.
Figure 4 shows that AIRE+ cells in the thymus were pre-
dominantly confined in the medullary region in CCR7- or
CCR7L-deficient mice as well as in normal mice (Figures
4A and 4B). The analysis at high magnification showed
that in the thymus of CCR7- or CCR7L-deficient mice
as well as in normal mice, AIRE expression was found
in the nuclei, as previously reported (Bjorses et al.,
1999; Rinderle et al., 1999), and in a fraction of kera-
tin+MTS-10+ mTEC (Figure 4C). It was also shown that
in CCR7- or CCR7L-deficient mice, as in normal mice,
CD11c+ DCs were predominantly localized in the me-
dulla, although some CD11c+ DCs were sparsely found
in the cortex even in normal mice (Figures 4D and 4E).
These results indicate that similar to that of normal
mice, AIRE in the thymus of CCR7- or CCR7L-deficient
mice are predominantly expressed in the medulla by
a fraction of mTEC. The results also show that DCs in
the thymus are enriched in the medulla in CCR7- or
CCR7L-deficient mice, indicating that CCR7 signals
are not required for the accumulation of DCs in the thy-
mic medulla. The results suggest that developing thy-
mocytes in CCR7- or CCR7L-deficient mice, which are
not accumulated in the medulla, may fail to directly inter-
act with AIRE+ mTEC.Thymocytes Generated in CCR7L-Deficient Mice Are
Potent in Inducing Autoimmune Exocrinopathy
The above results raised the possibility that the estab-
lishment of thymic-medulla-dependent central toler-
ance to organ-specific antigens might be affected in
CCR7- or CCR7L-deficient mice. We thus examined var-
ious organs of these mutant mice for lesions that might
be associated with defective self-tolerance. As shown in
Figure 5, we found that the lacrimal glands, the parotid
glands, and the submandibular glands exhibited peri-
ductal lymphocyte infiltration in CCR7- or CCR7L-defi-
cient mice (Figures 5A, 5B, and 5C). Lymphocyte infiltra-
tion in the lacrimal glands was accompanied by severe
tissue damage, including the destruction of acinar cells
(Figures 5A and 5D and Figure 6A). In mice up to 25
weeks old, the tissue damage was largely specific for
these exocrine glands, as no apparent lesions were de-
tected in other organs, including the trachea, thyroid,
liver, spleen, kidney, intestine, adrenal gland, and ovary
(data not shown). The lesions in these exocrine glands
were detected in all the tested mutant mice (n = 14 for
plt/pltmice; n = 5 for CCR7-deficient mice), even as early
as 5 weeks old (Figure 5D), and were found similarly in
CCR7L-deficient mice of BALB/c background as well
as C57BL/6 background (Figures 5A, 5B, and 5C). The
infiltrated lymphocytes were mostly CD4+ T cells and B
cells, and tissue-reactive antibodies were markedly de-
posited in the damaged tissues (Figures 6B and 6C).
These results indicate that CCR7- or CCR7L-deficient
mice exhibit autoimmune exocrinopathy resembling
Sjo¨gren’s syndrome.
To examine whether the autoimmune exocrinopathy
is a direct consequence of the defect in thymocytes,
the CCR7L-deficient plt/plt thymocytes were trans-
ferred into RAG2-deficient mice that lacked T cells and
B cells. Under this experimental condition, the plt/plt
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the host RAG2-deficient mice were not defective in
CCR7L expression. CCR7-expressing plt/plt-derived T
cells would normally migrate to CCR7L-expressing
host tissues, including lymph nodes and exocrine
glands, in the RAG2-deficient mice. Thus, the defect in
CCR7/CCR7L signaling in this cell transfer experiment
would be limited to the period of thymocyte develop-
ment before the cell transfer, and the transferred thymo-
cyte-derived T cells would exhibit no or little aberrancy
in the peripheral distribution after the cell transfer. As
shown in Figures 7A and 7B, the transfer of CCR7L-de-
ficient plt/plt thymocytes as well as plt/plt spleen cells
caused significant lymphocyte infiltration in the lacrimal
and salivary glands. By contrast, the transfer of control
+/plt thymocytes or +/plt spleen cells did not cause
such lymphocyte infiltration (Figures 7A and 7B). These
results indicate that the thymocytes generated without
CCR7L are potent in inducing autoimmune exocrinop-
athy in mice and, thus, are defective in establishing cen-
tral tolerance.
It was previously shown that plt/plt or CCR7-deficient
mice are defective in forming the medullary architecture
characterized by clusters of UEA-1+ cells (Ueno et al.,
2004). We finally addressed whether the defective cen-
tral tolerance in the thymus lacking CCR7 or CCR7L is
due to defective thymocyte accumulation in the medulla
or defective architecture of the medullary stroma. To this
end, we generated mixed bone marrow chimeras recon-
stituted with equal numbers of bone marrow cells from
CCR7-deficient mice and normal mice and examined
whether these mixed bone marrow chimeras might ex-
hibit the autoimmune exocrinopathy. Due to the pres-
ence of normal bone-marrow-derived thymocytes, it
was presumed that the medullary architecture in the
mixed bone marrow chimeras would appear normal
even in the presence of CCR7-deficient thymocytes. In-
deed, normal architecture of the medullary region con-
taining the UEA-1+ clusters was detected in the mixed
bone marrow chimeras, which was similar to that in the
normal bone marrow chimeras and different from that
in CCR7-deficient bone marrow chimeras (Figure 7C),
whereas the accumulation of CD45.2+ CCR7-deficient
thymocytes in the medulla was severely defective in
the mixed bone marrow chimeras (Figure 7D). However,
these mixed bone marrow chimeras exhibited the auto-
immune phenotypes in the lacrimal glands, including
lymphocyte infiltration and tissue damage, similar to
the bone marrow chimeras reconstituted with CCR7-
deficient bone marrow cells alone (Figures 7E and 7F).
These results indicate that CCR7-deficient bone-mar-
row-derived cells that are reconstituted in the normal
thymus architecture are potent in inducing autoimmune
exocrinopathy, suggesting that the autoimmune pheno-
type in CCR7-deficient mice is likely due to the lack of
thymocyte accumulation in the medulla rather than the
defective development of the medullary architecture.
These results also indicate that CCR7-deficient bone-
marrow-derived cells that are reconstituted in the pres-
ence of normally developing hematopoietic cells are still
potent in inducing autoimmune exocrinopathy, suggest-
ing that the autoimmunity in these mutant mice may be
caused even in the presence of normally generated
immune cells, including regulatory T cells.Discussion
The present results show that mature thymocytes are
normally generated in developmental kinetics and are
normally exported in CCR7- or CCR7L-deficient adult
mice. The pharmacological inhibition of S1P-mediated
thymocyte egress shows that in the absence of CCR7
signals, the mature thymocytes are accumulated in the
thymic cortex rather than the thymic medulla, suggest-
ing that the S1P-mediated thymocyte egress may occur
in the thymic cortex of these mutant mice. These results
argue the possibility that the thymic medulla may not be
required for the maturation or export of thymocytes. On
the other hand, our results also show that in the absence
of CCR7 signals, the mature thymocytes are incapable
of acquiring tolerance to lacrimal and salivary glands
and are potent in inducing autoimmune exocrinopathy.
Thus, CCR7-mediated cortex-to-medulla migration of
positively selected thymocytes is essential for establish-
ing central tolerance rather than for supporting the mat-
uration or export of thymocytes.
The Cortex and Thymocyte Export
Our results show that the developmental kinetics and
the thymic export of SP thymocytes are undisturbed in
adult mice lacking CCR7 or CCR7L. FTY720 treatment
shows that the mature thymocytes are accumulated in
the thymic cortex of CCR7- or CCR7L-deficient mice,
unlike the accumulation in the medulla of normal mice.
FTY720-sensitive S1P-dependent chemotaxis is essen-
tial for the egress of mature thymocytes to the circula-
tion (Matloubian et al., 2004). Thus, the present results
suggest that the mature thymocytes generated in
CCR7- or CCR7L-deficient mice may be exported from
the cortex without migrating into the medulla. It has
been generally thought that the medulla is a place for
the maturation and export of thymocytes (Ritter and
Boyd, 1993; Scollay and Godfrey, 1995; Anderson and
Jenkinson, 2001). Indeed, our results from the FTY720
treatment of normal mice agree with the notion that
S1P-dependent thymocyte export occurs in the medulla
of normal mice (Figure 3). However, our results also sug-
gest the possibility that in the case that the positively se-
lected thymocytes remain in the cortex without being at-
tracted to CCR7L expressed in the medulla, the thymic
cortex can not only nurture the maturation of SP thymo-
cytes but also export the mature thymocytes. Based on
these results, we propose the possibility that the thymic
cortex may have the capability of fully supporting the
development of T cells, including SP thymocyte matura-
tion and the export of mature T cells. This possibility is
consistent with previous findings that T cell maturation
and peripheral supply are not perturbed in relB-deficient
mice that lack the thymic medulla (Burkly et al., 1995).
It should be noted that we detected a minor fraction of
mature SP thymocytes in the medullary areas of CCR7-
or CCR7L-deficient mice (Ueno et al., 2004). However,
FTY720 treatment does not cause the accumulation of
mature thymocytes in the medulla of CCR7- or CCR7L-
deficient mice (Figure 3), arguing the possibility that
those medullary thymocytes in CCR7- or CCR7L-defi-
cient mice do not represent mature thymocytes whose
S1P-dependent egress from the thymus is blocked. It
is even unclear whether those medullary thymocytes in
Immunity
170Figure 3. FTY720-Mediated Accumulation of Mature Thymocytes in the Thymic Cortex of CCR7- or CCR7L-Deficient Mice
Frozen sections of the thymus from indicated mice were two-color or three-color stained for CD62L (green) and mTEC-specific ER-TR5 (red) (A);
CD62L (green), CD31 (blue), and ER-TR5 (red) (B); ER-TR4 (green), CD31 (blue), and ER-TR5 (red) (C); or CD62L (green), CD31 (blue), and ER-TR7
(red) (C), as indicated. The cortex and the medulla in (B) were identified by staining of the adjacent sections with cTEC-specific ER-TR4 and
mTEC-specific ER-TR5. The high magnification images in (B) show that in the cortex of FTY720-mediated CCR7L-deficient mice (P/P) and
CCR7-deficient mice (7/7) and in the medulla of FTY720-mediated control mice (+/P and +/7), there are the areas where many CD62Lhigh thymo-
cytes were accumulated around CD31+ endothelial vessels. It should be noted that low-magnification images of the cortex in the FTY720-treated
mutant mice (P/P and 7/7) and of the medulla in the FTY720-treated control mice (+/P and +/7) show that not all areas in the cortex are uniformly
filled with CD62Lhigh thymocytes and that there are also the cortical areas where only a few CD62Lhigh thymocytes were found (A). On the other
hand, no or very few CD62Lhigh thymocytes were found in the medulla of FTY720-mediated CCR7- or CCR7L-deficient mice (P/P and 7/7) and in
the cortex of FTY720-mediated control mice (+/P and +/7) in low-magnification as well as in high-magnification images (A and B).
(C) Serial sections were stained as indicated. The cortex (C) and the medulla (M) were identified by ER-TR4 and ER-TR5. The perivascular space
(PVS) was identified as the areas surrounded by CD31+ endothelial and ER-TR7+ mesenchymal cells. High-magnification images of boxes 1, 2, 3,
Cortex-Medulla Migration in Central Tolerance
171Figure 4. Intrathymic Distribution of AIRE-Expressing Cells and DCs in CCR7- or CCR7L-Deficient Mice
(A–C) Thymus sections from B6 (+/+), plt/plt (P/P), and CCR7-deficient (7/7) adult mice were stained with anti-AIRE (green), anti-keratin (blue),
and mTEC-specific MTS-10 (red) antibodies. Cortex (C) and medulla (M) were identified with MTS-10 staining (B). High-magnification images
from the three-color staining in (C) show that AIRE, keratin, and the MTS-10 determinant in the mutant mice as well as in the control mice are
expressed in single mTEC, although AIRE is selectively localized in the nuclei whereas keratin and MTS-10 determinants are predominantly lo-
calized at the cytoplasm and the plasma membrane, respectively.
(D and E) Thymus sections from indicated mice were also stained for CD11c (green) and ER-TR5 (red).
Shown are representative results of more than three independent analyses.the mutant mice may represent mature thymocytes that
will eventually be exported from the thymus. Neverthe-
less, it is possible that some mature thymocytes in
CCR7- or CCR7L-deficient mice may egress from the
thymus through the medullary and/or cortico-medullary
junction areas.
Perhaps, however, it is more tempting to speculate
that the minor fraction of mature thymocytes found in
the medulla of CCR7- or CCR7L-deficient mice may con-
tribute to the crosstalk signals to induce the generation
of AIRE+ mTEC in the medullary area. It was previously
shown that the generation of mature SP thymocytes is
essential for the development of the medullary epithelial
architecture (van Ewijk et al., 1994). On the other hand,
CCR7- or CCR7L-deficient mice generate the thymus
with a small but distinct medullary region (Ueno et al.,
2004) that contains AIRE+ mTEC as well as DCs (Fig-
ure 4), even though the generation of UEA-1+ clusters
in the medulla is impaired (Ueno et al., 2004; also shown
in Figure 7 of this study). Thus, it is possible that the
CCR7-independent migration into the medulla by a small
fraction of mature thymocytes may play a role in the de-
velopment of TEC precursor cells to generate AIRE+
mTEC and the localization of DCs in the medulla.
The perivascular space in the postnatal thymus is dis-
tributed around the venules and some arterioles and is
enriched in the medulla and the cortico-medullary junc-
tion (Ushiki, 1986; Kato, 1997). However, the perivascu-lar space is also found within the cortex in normal
animals (Ushiki, 1986; Kato, 1997; F.S. and Y.T., unpub-
lished data). It has been speculated that the perivascular
space is a route for T cell egress from the thymus paren-
chyma to the circulation (Ushiki, 1986; Kato, 1997). In-
deed, our results show that the FTY720-mediated block-
ade of the S1P-dependent egress results in the
accumulation of mature thymocytes even in the perivas-
cular space that is localized in the medulla of normal
mice (Figure 3C), supporting the possibility that the
medullary perivascular space is a route for the S1P-de-
pendent T cell egress from the thymus in normal mice.
Interestingly, however, in mice deficient in CCR7 or
CCR7L, the FTY720 treatment accumulates most ma-
ture thymocytes in the cortex rather than in the medulla.
The accumulation in these mutant mice is detected even
in the perivascular space within the cortex (Figure 3C).
These results not only reinforce the possibility that the
cortex is capable of supporting T cell export, but also
support the possibility that the perivascular space within
the cortex can serve as a route for the S1P-dependent
egress of mature thymocytes. Thus, our results suggest
that the cortex-to-medulla migration of developing thy-
mocytes may not be required for the further maturation
of thymocytes or for the export of mature thymocytes.
The possibility that similar to the medulla, the cortex
can support the generation and export of mature SP
thymocytes prompts us to question why the maturationand 4 show the representative areas of cortical PVS in +/P mice, medullary PVS in +/P mice, cortical PVS in P/P mice, and medullary PVS in P/P
mice, respectively. Arrows in the high-magnification images (1–4) indicate the representative PVSs, which are also schematically depicted in the
right panels. Shown are representative results of more than ten independent analyses.
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Exhibit Lymphocyte Infiltration in Lacrimal
and Salivary Glands with Tissue Damage
Representative hematoxylin- and eosin-
stained tissue sections of lacrimal glands
(A), parotid glands (B), and submandibular
glands (C) from CCR7L-deficient mice (plt/
plt, P/P), CCR7-deficient mice (7/7), and their
heterozygous control mice (+/P and +/7) are
shown. Where indicated, the sections were
obtained from plt/plt (P/P) and +/plt (+/P)
mice of BALB/c background.
(D) Histological grading of inflammatory le-
sions in plt/plt (P/P; closed circles) and +/plt
(+/P; open circles) mice at the indicated age
was performed as described in the Experi-
mental Procedures. Double asterisk indi-
cates p < 0.005 and triple asterisk indicates
p < 0.0005 by the Mann-Whitney test.and export of SP thymocytes in normal mice occur pre-
dominantly in the medulla rather than in the cortex. In
agreement with previous reports (Matloubian et al.,
2004; Allende et al., 2004), our results show that S1P1,
the receptor for S1P in T cells, is expressed predomi-
nantly by CD62LhighCD69low mature SP thymocytes
rather than by the less immature thymocytes, including
DN, DP, and CD62LlowCD69high SP cells. It is therefore
likely that most thymocytes, including the DN and
DP immature cortical thymocytes as well as the
CD62LlowCD69high semimature SP thymocytes, are not
attracted to S1P, even though neighboring vascula-
tures in the cortex may supply a gradient of S1P toward
the circulation. On the other hand, positively selected
DP thymocytes begin expressing a low level of CCR7
(Ueno et al., 2004), and CCR7 is clearly expressed on
the positively selected thymocytes at the semimature
CD62LlowCD69high SP thymocyte stage (Figure 1). Thus,
it is likely that in normal mice, positively selected thymo-
cytes in the cortex are attracted to CCR7L, which is pre-
dominantly expressed in the medulla, but not attracted
to S1P, which penetrates from the vasculature even in
the cortex, so that the majority of the positively selected
thymocytes are attracted to and accumulated in the
medulla. Upon completion of thymocyte differentiation,
the S1P1-expressing mature SP thymocytes may be
exported to the circulation via the perivascular space
within either the medulla or the cortex.It is also interesting to note that CD62L+ cells are
sparsely found in the cortex, rather than in the medulla,
of the normal untreated mice (Figure 3A), in agreement
with previous reports (Reichert et al., 1984; Fink et al.,
1985). It was reported that CD62L+ cortical thymocytes
in normal untreated mice are generated before birth
and contain immature DN cells (Reichert et al., 1986a,
1986b), whereas CD62Lhigh mature SP thymocytes are
rare in untreated mice and are increased in number
upon FTY720 treatment within the medulla of normal
mice (Figures 2C and 3A). The developmental status,
particularly the significance in thymocyte export, of the
CD62L+ cells visualized in the cortex of normal untreated
mice is still unclear and warrants further analysis.
Medulla Migration and Central Tolerance
Our results show that CCR7- or CCR7L-deficient mice
exhibit autoimmune dacryoadenitis and sialadenitis
with antibody deposit and tissue damage and that this
exocrinopathy is reproduced in lymphocyte-lacking
RAG2-deficient mice that are transferred with thymo-
cytes from CCR7L-deficient mice. These results indicate
that the thymocytes that are generated without CCR7
signals do not fully establish self-tolerance to the or-
gans, such as lacrimal and salivary glands. Because thy-
mocytes that develop in CCR7- or CCR7L-deficient mice
fail to accumulate in the medulla and may be exported
directly from the cortex, and because AIRE+ cells in the
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173Figure 6. CCR7- or CCR7L-Deficient Mice
Exhibit Autoimmune Exocrinopathy
(A) Representative sections of indicated exo-
crine glands from CCR7L-deficient plt/plt
mice (P/P) and CCR7-deficient mice (7/7)
show that acinar cells in the lacrimal and pa-
rotid glands are definitively destoyed in the
mutant mice, presenting clear evidence of tis-
sue damage in the mutant mice.
(B and C) Serial sections of lacrimal glands
from B6 mice (B) and CCR7L-deficient plt/
plt mice (P/P) (C) were stained with hematox-
ylin and eosin or with indicated antibodies.
Antibodies used were specific for B220
(green), Thy-1 (red), CD4 (green), CD8 (red),
and IgG (green). Shown are representative re-
sults of four independent analyses.thymus are predominantly confined within the medulla
even in CCR7- or CCR7L-deficient mice, it is possible
that the thymocytes generated in CCR7- or CCR7L-defi-
cient mice are unable to establish self-tolerance to
a spectrum of organ-specific antigens because the
developing thymocytes fail to interact with AIRE+ mTEC
localized in the medulla.
It is interesting to note that similar to CCR7- or
CCR7L-deficient mice, AIRE-deficient mice as well as
AIRE-deficient APECED patients manifest autoimmune
dacryoadenitis and sialadenitis (Anderson et al., 2002;
Liston et al., 2003; Kuroda et al., 2005), suggesting that
a similar mechanism for the breakdown of central toler-
ance may be involved in the autoimmunity in these
cases. The autoimmune phenotype in CCR7- or
CCR7L-deficient mice is mild and restricted to lacrimal
and salivary glands. It has been reported that the auto-
immune phenotype in AIRE-deficient mice of C57BL/6
background is also mild, being largely limited to lacrimal
and salivary glands (Jiang et al., 2005; Kuroda et al.,
2005). Thus, the autoimmune phenotype in CCR7- or
CCR7L-deficient mice and in AIRE-deficient mice is sim-
ilarly mild and similarly restricted to lacrimal and salivary
glands, at least in the C57BL/6 background. Whether or
not the autoimmune phenotype in CCR7- or CCR7L-de-
ficient mice of other genetic backgrounds, particularly
the autoimmune-prone NOD background, may be
broader and more severe, similar to the phenotype of
AIRE-deficient mice, is still unclear and will be ad-
dressed in a separate study.
Nonetheless, AIRE-deficient mice of different genetic
backgrounds as well as many APECED patients mani-
fest autoimmunity with a spectrum that appears much
wider than dacryoadenitis and sialadenitis in CCR7- orCCR7L-deficient mice of the C57BL/6 background (Nag-
amine et al., 1997; Aaltonen et al., 1997; Anderson et al.,
2002; Jiang et al., 2005). It was recently shown that cen-
tral tolerance to organ-specific antigens is induced not
only directly by mTEC antigen presentation but also in-
directly by bone-marrow-derived antigen-presenting
cells such as DCs (Gallegos and Bevan, 2004). Our re-
sults show that DCs in the thymus of CCR7- or
CCR7L-deficient mice are normally distributed in the
cortex as well as in the medulla (Figure 4). Thus, the
more restricted autoimmunity in CCR7- or CCR7L-defi-
cient mice may be due at least in part to central toler-
ance to DC-mediated crosspresentation of a fraction
of AIRE-dependent, organ-specific antigens expressed
by mTEC. The milder autoimmunity in CCR7- or
CCR7L-deficient mice than in AIRE-deficient mice may
also be affected by the compromised immune re-
sponses in CCR7- or CCR7L-deficient mice, which are
caused by the delayed lymphocyte homing to second-
ary lymphoid organs (Forster et al., 1999), even though
our results show that the similarly mild autoimmune exo-
crinopathy is caused even in RAG2-deficient mice re-
constituted with plt/plt thymocytes (Figure 7) in which
CCR7/CCR7L signaling in peripheral mature T cells
would exhibit no or little aberrancy. How the autoimmu-
nity in CCR7-, CCR7L-, or AIRE-deficient mice is limited
to dacryoadenitis and sialadenitis in the C57BL/6 back-
ground is still unclear.
We think it is possible that the clonal deletion of self-
reactive thymocytes that are specific for a spectrum of
organ-specific antigens may be affected in CCR7- or
CCR7L-deficient mice, because the thymocytes from
these mutant mice exhibit a significantly higher autolo-
gous mixed lymphocyte reaction than those from
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Defective Medulla Accumulation of Thymo-
cytes
(A and B) Thymocytes generated in CCR7L-
deficient mice are potent in inducing da-
cryoadenitis and sialadenitis. Thymocytes
and splenocytes from CCR7L-deficient plt/
plt mice (P/P) or control +/plt mice were
transferred into nonirradiated RAG2-deficient
mice. Histopathological analysis was carried
out 6 weeks after the cell transfer. Tissue sec-
tions of lacrimal glands were stained with
hematoxylin and eosin (A), and histological
grading was performed as described in the
Experimental Procedures (B).
(C–F) T cell-depleted bone marrow cells from
B6.SJL-Ptprca mice (Ly5.1; CD45.1
+CD45.22)
and/or CCR7-deficient mice (7/7;
CD45.12CD45.2+) were transferred into nonir-
radiated RAG2-deficient mice. Where indi-
cated, equal numbers of T cell-depleted
bone marrow cells from B6.SJL-Ptprca mice
and CCR7-deficient mice were transferred
(Ly5.1+7.7). Histological and flow cytometry
analyses were carried out 6–8 weeks after
the cell transfer. The thymuses were analyzed
with multicolor confocal microscopy (C) and
flow cytometry (data not shown). The UEA-1
and ER-TR5 two-color staining profiles indi-
cate that clusters of UEA-1+ cells in the me-
dulla are generated in the B6.SJL-Ptprca
bone marrow chimeras (Ly5.1) and the mixed
bone marrow chimeras (Ly5.1+7/7) but are
defective in the CCR7-deficient bone marrow
chimeras (7/7) (C). Flow cytometry analysis in-
dicated that every mouse used for the analysis
exhibited successful thymocyte reconstitu-
tion (2.0–2.5 3 108 cells per mouse) and that
the ratio of CD45.1+CD45.22 thymocytes to
CD45.12CD45.2+ thymocytes in the mixed
bone marrow chimeras was in the range of
40:60 to 60:40 (data not shown). The CD45.2
and CD45.1 two-color confocal analysis of
the thymus sections (D) along with the staining
of the adjacent sections with mTEC-specific
ER-TR5 and UEA-1 indicates that
CD45.12CD45.2+ CCR7-deficient thymocytes
are arrested in the cortex (C) and are defective
inaccumulating in themedulla (M)of themixed
bone marrowchimeras. Tissuesections of lac-
rimal glands were stained with hematoxylin
and eosin (E), and histological grading was
performed as described in the Experimental
Procedures (F). Asterisk indicates p < 0.05 by
the Mann-Whitney test; N.S., not significant.normal mice (H.K. and Y.T., unpublished data), because
the mixed bone marrow chimeras reconstituted with
bone marrow cells from CCR7-deficient mice and nor-
mal mice exhibit the autoimmune exocrinopathy (Fig-
ure 7) and because AIRE-expressing mTEC are shown
to regulate the deletion of forbidden thymocyte clones
(Liston et al., 2003) rather than the generation of regula-
tory T cells (Anderson et al., 2005). We are currently an-
alyzing whether the clonal deletion of organ-specific-
antigen-reactive thymocytes and/or the generation of
regulatory T cells may be defective in the thymus of
CCR7- or CCR7L-deficient mice.
We have previously reported that negative selection is
normally induced in male antigen-specific thymocytes inHY-TCR-transgenic mice and in allogeneic MHC-spe-
cific thymocytes in 2C-TCR-transgenic mice even in
the absence of CCR7L (Ueno et al., 2004), indicating
that negative selection to systemically ubiquitous anti-
gens is normally induced in the absence of CCR7 sig-
nals. Perhaps, negative selection to ubiquitous antigens
occurs in the cortex without migration to the medulla.
We have also shown that Mtv-specific deletion of Vb3+
and Vb5+ thymocytes is normally induced in CCR7L-de-
ficient mice (Ueno et al., 2004). It has been reported that
DCs in the thymus are primarily responsible for negative
selection of Mtv-reactive thymocytes (Moore et al.,
1994; Ferrero et al., 1997). Our results show that in
CCR7- or CCR7L-deficient mice as well as in normal
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sparsely in the cortex. Thus, it is possible that the
sparsely localized DCs in the cortex may be capable of
inducing negative selection of Mtv-reactive thymocytes
in the absence of CCR7 signals and without the medulla
migration. The average lifespan of SP thymocytes in the
thymus is 12 days (Egerton et al., 1990; Scollay and God-
frey, 1995), and the developmental kinetics of the SP
thymocytes is undisturbed in the absence of CCR7 sig-
nals (Figure 1); thus, 12 days in the cortex may be suffi-
cient for developing SP thymocytes to be negatively se-
lected with Mtv-superantigens presented by DCs.
In conclusion, the present results indicate that the
CCR7-dependent accumulation of positively selected
thymocytes in the medulla is not essential for the matu-
ration or export of thymocytes, suggesting that similar
to the medulla, the thymic cortex may be capable of
supporting the development and export of mature thy-
mocytes. On the other hand, the cortex-to-medulla
migration of developing thymocytes is essential for es-
tablishing central tolerance, suggesting that the devel-
oping thymocytes need to directly interact with mTEC
in order to establish central tolerance to some organ-
specific antigens.
Experimental Procedures
Mice
CCR7-deficient mice (Forster et al., 1999) and CCR7L-deficient plt/
plt mice (Nakano et al., 1998) were backcrossed to C57BL/6 mice
for six generations. plt/plt mice of BALB/c background were also
used. RAG2-deficient mice and B6.SJL-Ptprca mice were kindly pro-
vided by Dr. F. Alt (Shinkai et al., 1993) and Dr. H. Nakauchi, respec-
tively. C57BL/6 (B6) mice were obtained from SLC, Shizuoka, Japan.
Mice were bred and maintained under specific pathogen-free condi-
tions in our animal facility, and experiments were performed with
consent from the Animal Experimentation Committee of the Univer-
sity of Tokushima.
BrdU Labeling
For the detection of BrdU incorporation, adult mice were injected in-
traperitoneally twice with 2 mg BrdU/mouse at 4 hr intervals. Thymo-
cytes were harvested at indicated time points after the injection.
Cells that incorporated BrdU were detected with an FITC BrdU
Flow Kit according to the manufacturer’s instructions (BD Biosci-
ences).
FTY720 Treatment
FTY720 (Novartis Pharma) was dissolved in saline and administered
into the peritoneal cavity of adult mice at the dose of 20 mg per day
for 10 days. Mice were analyzed on the day after the last administra-
tion.
Cell Transfer into RAG2-Deficient Mice
Thymocytes, splenocytes, or T cell-depleted bone marrow cells
from female mice (3 3 107) were injected intravenously into nonirra-
diated RAG2-deficient female mice. Mice were analyzed 6–8 weeks
after the cell transfer.
Multicolor Confocal Analysis
Frozen sections (5–10 mm) were fixed with acetone and stained with
the following antibodies: Alexa 488-conjugated anti-CD4 (GK1.5),
FITC-conjugated anti-B220 (RA3-6B2), Alexa 633-conjugated
mTEC-specific ER-TR5 (van Vliet et al., 1984), and Alexa 633-conju-
gated anti-mouse IgG antibodies. Alexa 546-conjugated UEA-1 was
also used. Biotinylated antibodies specific for CD8 (53-6-72), CD11c
(HL-3), CD31 (clone 390), Thy1.2 (30-H12), and CD45.2 (clone 104)
were visualized with Alexa 488-, Alexa 568-, or Alexa 633-conjugated
streptavidin (Molecular Probes). The staining with anti-CD62L (MEL-
14), cTEC-specific ER-TR4 (van Vliet et al., 1984), and fibroblast-spe-cific ER-TR7 (van Vliet et al., 1984) was visualized with Alexa 488- or
Alexa 633-conjugated anti-rat IgG (Molecular Probes). The staining
with anti-CD45.1 antibody (clone A20) was visualized with Alexa
633-conjugated anti-mouse IgG (Molecular Probes). The images
were acquired with a TCS SP2 confocal laser-scanning microscope
(Leica) equipped with Ar and He-Ne lasers (excitations at 488, 568,
and 633 nm) and analyzed with Leica Confocal software version 2.6.
Where indicated, frozen sections were labeled with rabbit anti-
mouse pan-cytokeratin antibody (wide screen, Dako), mTEC-spe-
cific MTS-10 (Godfrey et al., 1990), and anti-AIRE antibody (clone
5H12) (Liston et al., 2004) followed by Alexa 647-conjugated anti-
rabbit IgG (Molecular Probes), biotinylated anti-rat IgM (Southern
Biotech), and FITC-labeled anti-rat IgG2c (Southern Biotech) anti-
bodies. Biotinylated antibody was visualized with Alexa 568-conju-
gated streptavidin. The confocal images were acquired with a Bio-
Rad MRC 1024 with a three-line Kr/Ag laser (excitations at 488,
568, and 647 nm) and were analyzed with Bio-Rad LaserSharp soft-
ware version 3.2.
Histopathology
Paraformaldehyde-fixed tissues were embedded in paraffin. The
sections (4 mm) were stained with hematoxylin and eosin. Histolog-
ical grading of inflammatory lesions was carried out according to the
method originally reported by White and Casarett (1974) as follows
(Ishimaru et al., 2000): a score of 1 indicates that one to five foci be-
ing composed of more than 20 mononuclear cells per focus were
seen; a score of 2 indicates that more than five such foci were
seen but without significant parenchymal damage; a score of 3 indi-
cates degeneration of parenchymal tissue; and a score of 4 indicates
extensive infiltration of the glands with mononuclear cells and exten-
sive parenchymal damage.
Multicolor Flow Cytometry Analysis
Single-cell suspensions were stained with FITC-labeled, PE-labeled,
APC-labeled, and/or biotinylated antibodies as described (Ueno
et al., 2002, 2004). Biotinylated antibodies were detected with PE-
or APC-conjugated streptavidin (Molecular Probes) or Cy7-APC-
conjugated streptavidin (Caltag Laboratories). Labeled monoclonal
antibodies and normal IgG controls were obtained from BD Bio-
sciences and eBiosciences. Staining with CCL19-Ig (a gift from
Dr. Kunio Hieshima) was visualized with biotinylated anti-human
IgG and APC-conjugated streptavidin (Ueno et al., 2004). Multicolor
flow cytometry analysis was performed with two-laser FACS-Calibur
or FACS-Vantage (Becton Dickinson). Data were obtained with Cell
Quest software for viable cells that were determined based on mea-
surements of forward light scatter intensity and propidium iodide
exclusion.
Quantitative RT-PCR Analysis
Total cellular RNA was reverse-transcribed by using SuperScript II
Reverse Transcriptase (Life Technologies) and oligo-dT oligonucle-
otide. cDNA was polymerase chain reaction (PCR) amplified with
a SYBR Green PCR Master Mix and an ABI PRISM Sequence Detec-
tion System (Applied Biosystems) for CCR7 (50-TGTACGTCAGTA
TCACCAGC-30 and 50-TTTTCCAGGTGTGCTTCTGC-30), S1P1 (50-
GTGTAGACCCAGAGTCCTGCG-30 and 50-AGCTTTTCCTTGGCTG
GAGAG-30), and GAPDH (50-CCGGTGCTGAGTATGTCGTG-30 and
50-CAGTCTTCTGGGTGGCAGTG-30). Amplified signals were con-
firmed to be single bands by using gel electrophoresis and were nor-
malized to GAPDH levels.
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